A5013315640- Vaccine Coverage and Hesitancy
- Influenza Virus Research Studies
- SARS-CoV-2 and COVID-19 Research
- Respiratory viral infections research
- Child and Adolescent Health
- Virology and Viral Diseases
- Rabies epidemiology and control
- Viral gastroenteritis research and epidemiology
- Data-Driven Disease Surveillance
- Viral Infections and Vectors
- Pediatric health and respiratory diseases
- Herpesvirus Infections and Treatments
- COVID-19 epidemiological studies
- Clinical practice guidelines implementation
- COVID-19 Impact on Reproduction
- Hepatitis B Virus Studies
- Poxvirus research and outbreaks
- Zoonotic diseases and public health
- Bacterial Infections and Vaccines
- Interdisciplinary Research and Collaboration
- Delphi Technique in Research
- Nursing Diagnosis and Documentation
- Emergency and Acute Care Studies
- Health and Medical Research Impacts
- Vector-Borne Animal Diseases
National Centre for Immunisation Research & Surveillance
2024
Sydney Children’s Hospitals Network
2024
Hunter New England Local Health District
2014-2023
University of Newcastle Australia
2015-2023
Hunter Medical Research Institute
2016
New South Wales Department of Health
2014
Understanding the mental shortcuts people make and values they bring to weighing risks is critical informing effective risk communication On 8 April 2021, Australian Technical Advisory Group on Immunisation (ATAGI) made Pfizer Comirnaty (BNT162b2[mRNA]) coronavirus disease 2019 (COVID-19) vaccine preferred for adults aged under 50 years who have not received a first dose of COVID-19 AstraZeneca (ChAdOx1-S).1 This followed an established causal relationship between rare clotting condition...
This study uses data collected by Australia’s vaccine safety surveillance system to examine the adverse event profile of modified vaccinia Ankara–Bavarian Nordic vaccine.
Objective To assess the short term safety of COVID-19 vaccines Comirnaty (Pfizer–BioNTech BNT162b2) and Vaxzevria (AstraZeneca ChAdOx1) in Australia. Design Prospective observational cohort study; online surveys by AusVaxSafety, a national active vaccine surveillance system, three eight days after vaccination. Setting, participants People aged 16 years or more who received at sentinel vaccination hubs, general practices, Aboriginal Community Controlled Health Organisation clinics, 22...
Objective To actively solicit adverse events experienced in the days following immunisation with quadrivalent inactivated influenza vaccine using Australia’s near real-time, participant-based safety surveillance system, AusVaxSafety. Design and setting Observational cohort study conducted 194 sentinel sites (primary care, hospital community-based clinics) across Australia. Participants Individuals aged ≥6 months who received a routine seasonal at participating site (n=102 911) responded to...
Vaxtracker is a web based survey for active post marketing surveillance of Adverse Events Following Immunisation. It designed to efficiently monitor vaccine safety new vaccines by early signal detection serious adverse events. The system automates contact with the parents or carers immunised children email and/or sms message their smart phone. A hyperlink on and text messages links exploring events following immunisation. concept was developed during 2011 (n = 21), piloted 2012 200) 2013...
Increased febrile reactions in Australian children from one influenza vaccine brand 2010 diminished confidence immunisation, highlighting the need for improved safety surveillance. AusVaxSafety , a national surveillance system collected adverse events young 2015 brands real time through parent/carer reports via SMS/email. Weekly cumulative data on 3,340 demonstrated low rates of fever (4.4%) and medical attendance (1.1%). Fever was more frequent with concomitant vaccination.
Flying foxes (megachiroptera) and insectivorous microbats (microchiroptera) are the known reservoirs for a range of recently emerged, highly pathogenic viruses. In Australia there is public health concern relating to bats' role as Australian Bat Lyssavirus (ABLV), which has clinical features identical classical rabies. Three deaths from ABLV have occurred in Australia. A survey was conducted determine frequency bat exposures amongst adults Australia's most populous state, New South Wales;...
• COSSI is an Australian collaborative network for vaccination social science. Researchers, policy and program workers advocates benefit from alignment. The model has helped researchers to generate global impact. Other countries can learn the experience local action.
The "Staying Healthy in Child Care" Australian guidelines provide for illness and disease exclusions encourage vaccination of staff child care settings, however these requirements are not subject to accreditation licensing, their level implementation is unknown. This study aimed describe pertussis coverage workers a regional area northern NSW during 2010; review current practices; explore barriers vaccination. A cross sectional survey all centre directors the Hunter New England (HNE) was...
<h3>Importance</h3> Every year, influenza vaccines are administered to millions of people worldwide reduce morbidity and mortality from influenza. As new vaccine formulations increasingly used, monitoring comparing safety, in addition effectiveness, target populations essential. <h3>Objective</h3> To assess the postmarketing safety profile 2018 Southern Hemisphere vaccines, particularly 2 enhanced trivalent inactivated vaccines: an adjuvanted (aIIV3) high-dose (HD-IIV3), among Australian...
In August 2010, the United States Advisory Committee on Immunization Practices recommended that 2010–2011 CSL seasonal vaccine (Afluria) not be administered to children 6 months 8 years of age because risk febrile convulsion after immunization. This study reports a low rate (6%–7%) fever immunization with 2 non-CSL brands 2011 influenza in Australian <5 age. These data are reassuring for parents and healthcare workers regarding vaccination northern hemisphere.
Background Active participant monitoring of adverse events following immunization (AEFI) is a recent development to improve the speed and transparency vaccine safety postmarketing. Vaxtracker, an online tool used monitor safety, has successfully demonstrated its usefulness in postmarketing surveillance newly introduced childhood vaccines. However, use older participants, or for patients participating large clinical trials, not been evaluated. Objective The objective this study was AEFIs...
Australia commenced its COVID-19 vaccine program for children aged 12–15 years from July 2021 and 5–11 January 2022 with two primary doses of either Comirnaty (Pfizer–BioNTech BNT162b2, 10 μg 30 years) or Spikevax (Moderna mRNA-1273, 50 6–11 100 years), 8 weeks apart. A booster dose is recommended those 5–15 complex health conditions severe immunocompromise.
Australia commenced administration of the Spikevax (Moderna mRNA-1273) COVID-19 vaccine in August 2021 and Nuvaxovid (Novavax NVX-CoV2373) January 2022. This study describes short-term safety profile priming doses vaccines given between September 2023. Online surveys were sent via AusVaxSafety, Australia’s active surveillance system, three eight days after vaccination. A total 131,775 day 3 sent, with a response rate 38.5% (N = 50,721). 43,875 8 matched survey responses 71.5% 31,355). Half...
Objectives To assess the safety of live attenuated herpes zoster vaccine (ZVL) through cumulative analysis near real-time, participant-based active surveillance from Australia’s AusVaxSafety system. Design and setting ZVL was funded in Australia for adults aged 70 years November 2016, with a time-limited catch up programme those to 79 years. This cohort study monitored first two at 246 sentinel immunisation sites. Participants Adults 70–79 vaccinated who responded an opt-out survey sent via...
Abstract Aim This study aims to evaluate the effectiveness of HealthTracker, a surgical site infection surveillance system that improve notification for women after giving birth by caesarean section. Design protocol is an intervention called “HealthTracker” in monitoring infections post Methods will use mobile web application automatically send text message inviting all who give live baby section over six months during 2020–2021, at Australian tertiary referral hospital. The invites complete...